SCHEMBL18160293

SCHEMBL18160293

C(=C/c1[nH]c2ccccc2c1/C=C/c1cocn1)\c1cocn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.33
MAPT P10636 7/20 0.33
KMT2A Q03164 7/20 0.33
ALDH1A1 P00352 5/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 5/20 0.33
NPSR1 Q6W5P4 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP2D6 P10635 3/20 0.33
ALPG P10696 1/20 0.33
HTT P42858 1/20 0.33
ALK Q9UM73 1/20 0.33
TDO2 P48775 2/20 0.33
MCL1 Q07820 1/20 0.33
HSD17B10 Q99714 2/20 0.32
GPR3 P46089 1/20 0.32
FLT1 P17948 1/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18157784 0.86
SCHEMBL18157756 0.79 KMT2A (0.52) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18160337 0.75 NPC1 (0.34) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18160332 0.75 KDM4E (0.39) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18160299 0.74 NPC1 (0.35) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18157780 0.74 PADI4 (0.41) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18157765 0.73 ALK (0.50) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18157747 0.73 ALK (0.50) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18160294 0.72 MAPT (0.34) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL18157755 0.72 NPC1 (0.50) MEN1MAPTKMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION (US) 2019-03-26 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
WO-2016172193-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH RESEARCH FOUNDATION (US) 2016-10-27 WO disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents XPA, PPOX, ALAD MEN1 1398/4885MAPT 2538/4885KMT2A 2258/4885
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD MEN1 1398/4885MAPT 2538/4885KMT2A 2258/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD MEN1 1398/4885MAPT 2538/4885KMT2A 2258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.